Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Breast Cancer

  Free Subscription


2 AJR Am J Roentgenol
1 Am J Surg
1 Ann Oncol
3 Ann Surg Oncol
2 BMC Cancer
1 Breast Cancer
6 Breast Cancer Res
14 Breast Cancer Res Treat
2 Breast J
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
4 Cancer Res
7 Clin Breast Cancer
1 Curr Treat Options Oncol
2 Eur J Cancer
2 J Nucl Med
3 J Surg Oncol
2 Lancet Oncol
3 PLoS One
2 Pol J Radiol
1 Proc Natl Acad Sci U S A
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

    Editorial Comment on "Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study".
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24456.

  2. GREENWOOD HI, Freimanis RI
    Commentary on "Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening".
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23674.

    Am J Surg

  3. KENNEDY GT, Hill CM, Huang Y, So A, et al
    Enhanced recovery after surgery (ERAS) protocol reduces perioperative narcotic requirement and length of stay in patients undergoing mastectomy with implant-based reconstruction.
    Am J Surg. 2020;220:147-152.
    PubMed         Abstract available

    Ann Oncol

  4. MAYER EL, Abramson V, Jankowitz R, Falkson C, et al
    TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.
    Ann Oncol. 2020 Aug 13. pii: S0923-7534(20)42061.
    PubMed         Abstract available

    Ann Surg Oncol

  5. PANDA N, Solsky I, Hawrusik B, Liu G, et al
    Smartphone Global Positioning System (GPS) Data Enhances Recovery Assessment After Breast Cancer Surgery.
    Ann Surg Oncol. 2020 Aug 18. pii: 10.1245/s10434-020-09004.
    PubMed         Abstract available

  6. BOTTY VAN DEN BRUELE A, Lavery J, Plitas G, Pilewskie ML, et al
    Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Aug 19. pii: 10.1245/s10434-020-08863.
    PubMed         Abstract available

  7. ROSENKRANZ KM, Boughey JC
    ASO Author Reflections: Multiple Ipsilateral Breast Cancer: Where Have We Been, Where are We Going.
    Ann Surg Oncol. 2020 Aug 17. pii: 10.1245/s10434-020-08983.

    BMC Cancer

  8. PARE M, Darini CY, Yao X, Chignon-Sicard B, et al
    Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes.
    BMC Cancer. 2020;20:784.
    PubMed         Abstract available

  9. TOOHEY K, Pumpa K, McKune A, Cooke J, et al
    The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems.
    BMC Cancer. 2020;20:787.
    PubMed         Abstract available


  10. WISE J
    Breast cancer: study claiming that screening women in their 40s saves lives "found the opposite," say critics.
    BMJ. 2020;370:m3191.

  11. VAIDYA JS, Bulsara M, Baum M, Wenz F, et al
    Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    BMJ. 2020;370:m2836.
    PubMed         Abstract available

    Breast Cancer

  12. LOPEZ P, Galvao DA, Taaffe DR, Newton RU, et al
    Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage.
    Breast Cancer. 2020 Aug 19. pii: 10.1007/s12282-020-01147.
    PubMed         Abstract available

    Breast Cancer Res

  13. KLEMENT RJ, Champ CE, Kammerer U, Koebrunner PS, et al
    Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients.
    Breast Cancer Res. 2020;22:94.
    PubMed         Abstract available

  14. LO GULLO R, Daimiel I, Rossi Saccarelli C, Bitencourt A, et al
    MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.
    Breast Cancer Res. 2020;22:93.
    PubMed         Abstract available

  15. BERNHARDT SM, Dasari P, Wrin J, Raymond W, et al
    Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age.
    Breast Cancer Res. 2020;22:90.
    PubMed         Abstract available

  16. VAN GEELEN CT, Savas P, Teo ZL, Luen SJ, et al
    Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
    Breast Cancer Res. 2020;22:91.
    PubMed         Abstract available

  17. CHAO X, Liu L, Sun P, Yang X, et al
    Immune parameters associated with survival in metaplastic breast cancer.
    Breast Cancer Res. 2020;22:92.
    PubMed         Abstract available

  18. O'BRIEN NA, McDermott MSJ, Conklin D, Luo T, et al
    Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer.
    Breast Cancer Res. 2020;22:89.
    PubMed         Abstract available

    Breast Cancer Res Treat

  19. DIAMOND JR, Becerra C, Richards D, Mita A, et al
    Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.
    Breast Cancer Res Treat. 2020 Aug 14. pii: 10.1007/s10549-020-05817.
    PubMed         Abstract available

  20. LIANG R
    Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer".
    Breast Cancer Res Treat. 2020 Aug 14. pii: 10.1007/s10549-020-05853.

  21. GEORGE MA, Lustberg MB, Orchard TS
    Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet.
    Breast Cancer Res Treat. 2020 Aug 15. pii: 10.1007/s10549-020-05808.
    PubMed         Abstract available

  22. BRAAL CL, Hussaarts KGAM, Seuren L, Oomen-de Hoop E, et al
    Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
    Breast Cancer Res Treat. 2020 Aug 16. pii: 10.1007/s10549-020-05829.
    PubMed         Abstract available

  23. CAVALCANTE FP, Novita GG, Millen EC, Zerwes FP, et al
    Management of early breast cancer during the COVID-19 pandemic in Brazil.
    Breast Cancer Res Treat. 2020 Aug 16. pii: 10.1007/s10549-020-05877.
    PubMed         Abstract available

  24. RIEDEL F, Heil J, Feisst M, Moderow M, et al
    Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
    Breast Cancer Res Treat. 2020 Aug 20. pii: 10.1007/s10549-020-05876.
    PubMed         Abstract available

  25. DIXON JM, Grewar J, Twelves D, Graham A, et al
    Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer.
    Breast Cancer Res Treat. 2020 Aug 18. pii: 10.1007/s10549-020-05843.
    PubMed         Abstract available

  26. KIM JY, Jung HH, Sohn I, Woo SY, et al
    Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer.
    Breast Cancer Res Treat. 2020 Aug 18. pii: 10.1007/s10549-020-05874.
    PubMed         Abstract available

  27. KILBREATH SL, Ward LC, Davis GM, Degnim AC, et al
    Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial.
    Breast Cancer Res Treat. 2020 Aug 18. pii: 10.1007/s10549-020-05863.
    PubMed         Abstract available

  28. DE BOER AZ, van de Water W, Bastiaannet E, de Glas NA, et al
    Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison.
    Breast Cancer Res Treat. 2020 Aug 19. pii: 10.1007/s10549-020-05860.
    PubMed         Abstract available

  29. OGIYA R, Niikura N, Kumamaru H, Takeuchi Y, et al
    Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.
    Breast Cancer Res Treat. 2020 Aug 20. pii: 10.1007/s10549-020-05869.
    PubMed         Abstract available

  30. BAGHERZADEH M, Szymiczek A, Donenberg T, Butler R, et al
    Association of RAD51C germline mutations with breast cancer among Bahamians.
    Breast Cancer Res Treat. 2020 Aug 18. pii: 10.1007/s10549-020-05872.
    PubMed         Abstract available

  31. TEODOZIO CGC, Marchito LO, Fabro EAN, Macedo FO, et al
    Shoulder amplitude movement does not influence postoperative wound complications after breast cancer surgery: a randomized clinical trial.
    Breast Cancer Res Treat. 2020 Aug 17. pii: 10.1007/s10549-020-05826.
    PubMed         Abstract available

  32. KAZMI S, Chatterjee D, Raju D, Hauser R, et al
    Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.
    Breast Cancer Res Treat. 2020 Aug 17. pii: 10.1007/s10549-020-05867.
    PubMed         Abstract available

    Breast J

  33. ODIKPO LC, Chiejina EN
    Assessment of barriers to practice of exercise among women with breast cancer in Delta State, Nigeria.
    Breast J. 2020 Aug 17. doi: 10.1111/tbj.13989.

  34. GUVEN DC, Sahin TK, Aksoy S
    The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.
    Breast J. 2020 Aug 19. doi: 10.1111/tbj.14027.

    Cancer Epidemiol Biomarkers Prev

  35. MCCULLOUGH ML, Gapstur SM, Gaudet MM, Wang Y, et al
    Coffee Consumption and Invasive Breast Cancer Incidence among Postmenopausal Women in the Cancer Prevention Study II Nutrition Cohort.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 14. pii: 1055-9965.EPI-20-1051.
    PubMed         Abstract available

    Cancer Lett

  36. XIE Y, Hu Y, Zhou N, Yao C, et al
    CAR T-cell therapy for triple-negative breast cancer: Where we are.
    Cancer Lett. 2020 Aug 11. pii: S0304-3835(20)30400.
    PubMed         Abstract available

    Cancer Res

  37. AMBROSONE CB, Higgins MJ
    Relationships between breast feeding and breast cancer subtypes: lessons learned from studies in humans and in mice.
    Cancer Res. 2020 Aug 14. pii: 0008-5472.CAN-20-0077.
    PubMed         Abstract available

  38. CONWAY ME, McDaniel JM, Graham JM, Guillen KP, et al
    STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-20-1379.
    PubMed         Abstract available

  39. GALE M, Li Y, Cao J, Liu ZZ, et al
    Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition.
    Cancer Res. 2020;80:524-535.
    PubMed         Abstract available

  40. KONG T, Ahn R, Yang K, Zhu X, et al
    CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers.
    Cancer Res. 2020;80:444-457.
    PubMed         Abstract available

    Clin Breast Cancer

  41. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2020 Jul 24. pii: S1526-8209(20)30177.
    PubMed         Abstract available

  42. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2020 Jul 15. pii: S1526-8209(20)30172.
    PubMed         Abstract available

  43. MORIMOTO M, Toba H, Aoyama M, Nakagawa M, et al
    Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Jul 24. pii: S1526-8209(20)30178.
    PubMed         Abstract available

  44. KONISHI T, Fujiogi M, Michihata N, Morita K, et al
    Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan.
    Clin Breast Cancer. 2020 May 11. pii: S1526-8209(20)30094.
    PubMed         Abstract available

  45. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2020 Jul 23. pii: S1526-8209(20)30175.
    PubMed         Abstract available

  46. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2020 Jul 3. pii: S1526-8209(20)30156.
    PubMed         Abstract available

  47. BEKES I, Eichler M, Singer S, Friedl TWP, et al
    Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial.
    Clin Breast Cancer. 2020 Apr 6. pii: S1526-8209(20)30064.
    PubMed         Abstract available

    Curr Treat Options Oncol

  48. ANANDAN A, Sharifi M, O'Regan R
    Molecular Assays to Determine Optimal Duration of Adjuvant Endocrine Therapy in Breast Cancer.
    Curr Treat Options Oncol. 2020;21:84.
    PubMed         Abstract available

    Eur J Cancer

  49. RETEL VP, Byng D, Linn SC, Jozwiak K, et al
    Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial.
    Eur J Cancer. 2020;137:193-203.
    PubMed         Abstract available

  50. FRASCA M, Sabathe C, Delaloge S, Galvin A, et al
    Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
    Eur J Cancer. 2020;137:240-249.
    PubMed         Abstract available

    J Nucl Med

  51. BRAGINA O, von Witting E, Garousi J, Zelchan R, et al
    Phase I study of (99m)Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.248799. doi: 10.2967/jnumed.120.248799.
    PubMed         Abstract available

  52. VAN ES SC, Velleman T, Elias SG, Bensch F, et al
    Assessment of Bone Lesions with (18)F-FDG-PET Compared to (99m)Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.244640. doi: 10.2967/jnumed.120.244640.
    PubMed         Abstract available

    J Surg Oncol

  53. BERGER JM, Longhitano Y, Zanza C, Sener SF, et al
    Factors affecting the incidence of chronic pain following breast cancer surgery: Preoperative history, anesthetic management, and surgical technique.
    J Surg Oncol. 2020 Aug 19. doi: 10.1002/jso.26176.
    PubMed         Abstract available

  54. SINDONI A, Di Maria A, Fama' F
    Orbital metastases in infiltrating lobular carcinoma of the breast.
    J Surg Oncol. 2020;122:569.

  55. AL-ARNAWOOT B, Scaranelo A, Fleming R, Kulkarni S, et al
    Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
    J Surg Oncol. 2020;122:382-387.
    PubMed         Abstract available

    Lancet Oncol

    Final results of the UK Age trial on breast cancer screening age.
    Lancet Oncol. 2020 Aug 12. pii: S1470-2045(20)30428.

  57. DUFFY SW, Vulkan D, Cuckle H, Parmar D, et al
    Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
    Lancet Oncol. 2020 Aug 12. pii: S1470-2045(20)30398.
    PubMed         Abstract available

    PLoS One

  58. PEPLONSKA B, Janasik B, McCormack V, Bukowska-Damska A, et al
    Cadmium and volumetric mammographic density: A cross-sectional study in Polish women.
    PLoS One. 2020;15:e0233369.
    PubMed         Abstract available

  59. AMINA M, Al Musayeib NM, Alarfaj NA, El-Tohamy MF, et al
    Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials.
    PLoS One. 2020;15:e0237567.
    PubMed         Abstract available

  60. WAWRZYNIAK D, Grabowska M, Glodowicz P, Kuczynski K, et al
    Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
    PLoS One. 2020;15:e0237889.
    PubMed         Abstract available

    Pol J Radiol

  61. STEINHOF-RADWANSKA K, Grazynska A, Barczyk-Gutkowska A, Kajor M, et al
    The new method, the old problem - role of contrast-enhanced spectral mammography in the diagnosis of breast cancer among Polish women.
    Pol J Radiol. 2020;85:e381-e386.
    PubMed         Abstract available

  62. PISHDAD P, Moosavi A, Jalli R, Zarei F, et al
    How can additional ultrasonography screening improve the detection of occult breast cancer in women with dense breasts?
    Pol J Radiol. 2020;85:e353-e360.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  63. KHATIB A, Solaimuthu B, Ben Yosef M, Abu Rmaileh A, et al
    The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.
    Proc Natl Acad Sci U S A. 2020 Aug 18. pii: 2010275117.
    PubMed         Abstract available


  64. LUITEN JD, Voogd AC, Luiten EJT, Broeders MJM, et al
    Recall and Outcome of Screen-detected Microcalcifications during 2 Decades of Mammography Screening in the Netherlands National Breast Screening Program.
    Radiology. 2020 Jan 28:191266. doi: 10.1148/radiol.2020191266.
    PubMed         Abstract available

  65. ROCHAT CJ, Baird GL, Lourenco AP
    Digital Mammography Stereotactic Biopsy versus Digital Breast Tomosynthesis-guided Biopsy: Differences in Biopsy Targets, Pathologic Results, and Discordance Rates.
    Radiology. 2020 Jan 21:191525. doi: 10.1148/radiol.2019191525.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.